GRIFFON Pharmaceuticals is a biopharma company located in Montréal, Canada and Lausanne, Switzerland developing a new bifunctional peptide GRF and VIP analog. The company aims to develop GP119 in several indications with significant unmet needs. The company's lead indication, LD-HIV, is commonly seen in patients with HIV with an approximate prevalence of 200,000 patients in the US.
View Top Employees from Griffon Pharmaceuticals| Website | http://griffonpharma.com |
| Revenue | $3 million |
| Employees | 2 (2 on RocketReach) |
| Address | 7140 Rue Albert-Einstein, Montreal, Quebec H4S 2C1, CA |
| Industry | Manufacturing General, Manufacturing |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Griffon Pharmaceuticals employee's phone or email?
Griffon Pharmaceuticals Questions
The Griffon Pharmaceuticals annual revenue was $3 million in 2024.
2 people are employed at Griffon Pharmaceuticals.
Griffon Pharmaceuticals is based in Montreal, Quebec.
The NAICS codes for Griffon Pharmaceuticals are [32, 325, 3254, 32541].
The SIC codes for Griffon Pharmaceuticals are [28, 283].
Top Griffon Pharmaceuticals Employees
-
5+3
